The European Medicines Agency Recommends Sanofi-Aventis (France) Weight-Loss Pill

PARIS (AP) -- The European Medicines Agency has recommended an innovative new weight-loss pill for approval, the drug's maker, Sanofi-Aventis SA, announced Friday. Sanofi shares rose 2.7 percent to euro75.55 (US$94.72) in Paris after the agency's human medicines committee backed the new drug, Acomplia. The U.S. Food and Drug Administration issued an "approvable letter" for Acomplia in February, a step toward its approval for weight control.